| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Fundo de Investimento Imobiliário - FII Hospital da Criança Competitors
XTED - TRX Edificios Corporativos Fundo Invest Imobiliario FII Fund
BOVESPA:VVCO11
R$65.8m
Sp Downtown Fundo de Investimento Imobiliário - FII
BOVESPA:SPTW11
R$77.4m
Fundo Invest Imobiliario Centro Textil Internacional - Cotas Fund
BOVESPA:CTXT11
R$32.7m
RB Capital Renda I Fundo de Investimento Imobiliário - FII
BOVESPA:FIIP11B
R$167.9m
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$297.50 |
| 52 Week High | R$331.17 |
| 52 Week Low | R$220.00 |
| Beta | 0 |
| 1 Month Change | -0.87% |
| 3 Month Change | -2.48% |
| 1 Year Change | 28.93% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -4.03% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HCRI11 | BR Health Care REITs | BR Market | |
|---|---|---|---|
| 7D | -0.7% | 2.2% | -0.2% |
| 1Y | 28.9% | 0.08% | 13.7% |
Return vs Industry: HCRI11 exceeded the BR Health Care REITs industry which returned 2.7% over the past year.
Return vs Market: HCRI11 exceeded the BR Market which returned 13.9% over the past year.
Price Volatility
| HCRI11 volatility | |
|---|---|
| HCRI11 Average Weekly Movement | 1.4% |
| Health Care REITs Industry Average Movement | 3.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: HCRI11 has not had significant price volatility in the past 3 months.
Volatility Over Time: HCRI11's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | n/a |
Fundo de Investimento Imobiliário - FII Hospital da Criança Fundamentals Summary
| HCRI11 fundamental statistics | |
|---|---|
| Market cap | R$59.50m |
| Earnings (TTM) | -R$1.60m |
| Revenue (TTM) | R$8.58m |
0.0x
P/S Ratio0.0x
P/E RatioIs HCRI11 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HCRI11 income statement (TTM) | |
|---|---|
| Revenue | R$8.58m |
| Cost of Revenue | R$0 |
| Gross Profit | R$8.58m |
| Other Expenses | R$10.18m |
| Earnings | -R$1.60m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HCRI11 perform over the long term?
See historical performance and comparison